Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

BUY
$31.15 - $33.39 $4.92 Million - $5.28 Million
158,000 Added 496.75%
189,807 $6.3 Million
Q3 2022

Nov 07, 2022

BUY
$30.9 - $33.55 $834 - $905
27 Added 0.08%
31,807 $1 Million
Q4 2021

Feb 03, 2022

BUY
$17.46 - $21.61 $156,965 - $194,273
8,990 Added 39.45%
31,780 $663,000
Q3 2021

Oct 18, 2021

BUY
$17.35 - $22.5 $86,750 - $112,500
5,000 Added 28.11%
22,790 $438,000
Q2 2021

Aug 06, 2021

SELL
$18.01 - $28.32 $59,433 - $93,456
-3,300 Reduced 15.65%
17,790 $395,000
Q1 2021

Apr 26, 2021

SELL
$19.76 - $29.89 $51,376 - $77,714
-2,600 Reduced 10.98%
21,090 $554,000
Q4 2020

Jan 25, 2021

BUY
$15.73 - $21.66 $36,965 - $50,901
2,350 Added 11.01%
23,690 $443,000
Q3 2020

Oct 20, 2020

SELL
$13.54 - $26.41 $1,218 - $2,376
-90 Reduced 0.42%
21,340 $362,000
Q2 2020

Jul 27, 2020

BUY
$7.84 - $23.29 $26,303 - $78,137
3,355 Added 18.56%
21,430 $499,000
Q1 2020

Apr 17, 2020

SELL
$5.57 - $11.5 $176,569 - $364,550
-31,700 Reduced 63.69%
18,075 $152,000
Q4 2019

Jan 17, 2020

BUY
$7.9 - $10.14 $56,761 - $72,855
7,185 Added 16.87%
49,775 $486,000
Q3 2019

Oct 17, 2019

BUY
$9.17 - $12.01 $159,282 - $208,613
17,370 Added 68.87%
42,590 $404,000
Q2 2019

Jul 12, 2019

SELL
$10.88 - $17.6 $9,792 - $15,840
-900 Reduced 3.45%
25,220 $300,000
Q1 2019

Apr 17, 2019

BUY
$15.51 - $17.61 $17,061 - $19,371
1,100 Added 4.4%
26,120 $460,000
Q4 2018

Jan 17, 2019

BUY
$14.52 - $19.72 $2,904 - $3,944
200 Added 0.81%
25,020 $434,000
Q3 2018

Oct 16, 2018

BUY
$14.85 - $16.35 $19,305 - $21,255
1,300 Added 5.53%
24,820 $370,000
Q2 2018

Jul 19, 2018

BUY
$13.8 - $16.8 $124,200 - $151,200
9,000 Added 61.98%
23,520 $374,000
Q1 2018

Apr 10, 2018

BUY
$13.8 - $16.2 $20,700 - $24,300
1,500 Added 11.52%
14,520 $204,000
Q4 2017

Jan 12, 2018

BUY
$13.55 - $15.8 $84,010 - $97,960
6,200 Added 90.91%
13,020 $182,000
Q3 2017

Oct 13, 2017

BUY
$13.45 - $14.35 $91,729 - $97,867
6,820
6,820 $98,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.